Publications
Specialty
Search
EMSWorld
07/22/2024
Demers Ambulances USA is ensuring EMS/Fire crews and patients stay cool during the most extreme heat with its Arctic Range HVAC control package, available now in its MXP 170 Type I model.
Vascular Disease Management
07/22/2024
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
Oncology
07/22/2024
Paolo Ascierto, MD, discusses primary results from the phase 2 NEO-TIM trial which assessed the best sequencing of vemurafenib, cobimetinib, and atezolizumab among patients with high-risk melanoma.
APP Institute Inflammatory Bowel Disease
07/22/2024
Kimberly Orleck and Kim Kearns, APP Institute Inflammatory Bowel Disease cochairs, provide a quick preview of the exciting agenda for the inaugural two-day virtual event.
Advances in Inflammatory Bowel Disease Network
07/19/2024
“The safest treatment is often the treatment that effectively controls ulcerative colitis," Dr Christina Ha told the audience at the Advances in Inflammatory Bowel Disease regional meeting in Chicago, Illinois, July 19.
Journal of Invasive Cardiology, CardioVascular
07/19/2024
A 79-year-old man with the diagnosis of acute myocardial infarction complicating cardiogenic shock received Impella CP (Abiomed) insertion via a femoral approach.
Oncology
07/19/2024
Paolo Ascierto, MD, discusses primary results from the phase 2 NEO-TIM trial which assessed the best sequencing of vemurafenib, cobimetinib, and atezolizumab among patients with high-risk melanoma.
Psych Congress NP Institute
07/19/2024
True or False: Currently, there are no FDA-approved LAIs for patients under 18 years old with schizophrenia. Take the quiz!
Oncology
07/19/2024
David Spigel, MD, discusses the results from phase 3 ADRIATIC trial, evaluating durvalumab with or without tremelimumab as consolidation treatment for patients with limited-stage small-cell lung cancer.
Pharmacy Learning Network
07/19/2024
In this installment of Talking Therapeutics, Dr Jennings explores a new study that evaluates dapagliflozin against empagliflozin in patients with heart failure.
EMSWorld, Emergency & Mobile Medicine
07/19/2024
The Colorado Springs Fire Department stated that all of the computers in the 9-1-1 communications center were down, but 9-1-1 calls were still being received.
First Report Managed Care
07/19/2024
The jump in respiratory syncytial virus (RSV) cases after COVID-19-era social distancing and masking eased was partly due to increased testing in outpatient settings as well as changes to the RSV genome, according to a study published online in Nature Communications.
Pharmacy Learning Network
07/19/2024
In late June 2024, a month after the settlement with Totality Medispa, Eli Lilly filed 6 new lawsuits against medical spas and wellness centers across the country selling products allegedly containing tirzepatide. The lawsuits were filed in courts in Ohio, Texas, Hawaii, and the District of Columbia.
Today's Wound Clinic, Wound Care
07/19/2024
Misinformation about the use of an advanced beneficiary notice (ABN) of non-coverage is spreading like wildfire. This author presents the most common scenarios reported, answers to the ABN inquiries, and appropriate uses for ABNs.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
07/19/2024
“Having access to a patient’s whole coronary picture, with both quantified plaque and physiology, is a game-changer as a clinician. I can reference the cross-sectional views with plaque by type when reviewing my patient’s workup and have confidence in the accuracy and actionable insights that I know I’ll get from HeartFlow Plaque Analysis,” said Sarah Rinehart, MD, FACC, FSCCT.
Psych Congress NP Institute
07/19/2024
Gain insights into the considerations for initiating LAI antipsychotics and optimizing therapeutic plasma concentrations with Psych Congress NP Institute Steering Committee Member Desiree Matthews, PMHNP-BC.
Advances in Inflammatory Bowel Disease Network
07/19/2024
Dr Allegretti provides key take-home points from her presentation at the AIBD regional meeting on how anti-interleukin therapies work to treat both Crohn's disease and ulcerative colitis,
Wound Management & Prevention
07/18/2024
Wound Care
07/18/2024
Eluciderm, Inc. won the WHS WOUNDSHARK 2024 INNOVATION AWARD at the 2024 International Symposium for Advanced Wound Care (SAWC 2024) as recognition for the anticipated market impact of its groundbreaking ELU42, a first-of-its-kind, topically administered, small-molecule Wnt signaling pathway inhibitor.
First Report Managed Care, Population Health
07/18/2024
Learn why industry stakeholders should prepare for 2028 negotiations now to ensure long-term financial stability and regulatory compliance.